Evidence map›Paper›PMID 37358649›Full record

ArticleCurrent microbiology2023

Prediction of Effector Proteins from Trichoderma longibrachiatum Through Transcriptome Sequencing.

Jialin Zhang, Lijun Wang, Aizhi Ren, Yinsheng Sheng, Xue Chang, Xiaolong Li, Mengjiao Guan, Na Shang, Peibao Zhao, Shulei Sun

Abstract read
PubMed Publisher
In one paragraph

Article in Current microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Journal of fungi (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Jialin Zhang *Liaocheng University, Liaocheng, 252000, China.
Lijun Wang *Liaocheng University, Liaocheng, 252000, China.
Aizhi RenLiaocheng University, Liaocheng, 252000, China.
Yinsheng ShengLiaocheng University, Liaocheng, 252000, China.
Xue ChangLiaocheng University, Liaocheng, 252000, China.
Xiaolong LiLiaocheng University, Liaocheng, 252000, China.
Mengjiao GuanLiaocheng University, Liaocheng, 252000, China.
Na ShangLiaocheng University, Liaocheng, 252000, China.
Peibao ZhaoLiaocheng University, Liaocheng, 252000, China. zhaopeibao@lcu.edu.cn.ORCID http://orcid.org/0000-0002-2815-2722
Shulei SunLiaocheng University, Liaocheng, 252000, China. shuleisun@gmail.com.
Liaocheng University · CNUniversity of San Diego · US

Funding

Key Technology Research and Development Program of Shandong 2019GNC106018Natural Science Foundation of Shandong Province ZR2013CM006Natural Science Foundation of Shandong Province ZR2020MC125
6 · The paper itself

Abstract

Trichoderma longibrachiatum SMF2 is an important biocontrol strain isolated by our group that can promote plant growth and induce plant disease resistance. To further study its biocontrol mechanism, the effector proteins secreted by T. longibrachiatum SMF2 were analyzed through bioinformatics and transcriptome sequencing. Overall, 478 secretory proteins produced by T. longibrachiatum were identified, of which 272 were upregulated after treatment with plants. Functional annotation showed that 36 secretory proteins were homologous with different groups of effectors from pathogenic microorganisms. Moreover, the quantitative PCR results of six putative effector proteins were consistent with those of transcriptome sequencing. Taken together, these findings indicate that the secretory proteins secreted by T. longibrachiatum SMF2 may act as effectors to facilitate its own growth and colonization or to induce plant immunity response.

Indexed as

HypocrealesTrichodermaDisease ResistanceTranscriptome

Identifiers

PMID37358649
OpenAlexW4382010734

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.